http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Inari Medical (NARI) Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.
-
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.
-
Inari Medical Announces Joint Venture in Greater China
-
Inari Medical to Participate in the Jefferies London Healthcare Conference
-
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
-
Inari Medical Reports Third Quarter 2024 Financial Results
-
Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
-
Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation
-
Inari Medical to Announce Third Quarter 2024 Financial Results
-
Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024
-
Inari Medical to Present at Upcoming Investor Conferences
-
Inari Medical, Inc. (NARI) Announces CFO Retirement
-
Inari Medical Announces Chief Financial Officer Retirement and Succession Plan
-
Inari Medical Reports Second Quarter 2024 Financial Results
-
Inari Medical to Announce Second Quarter 2024 Financial Results
-
ROSEN, A LEADING NATIONAL FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
-
Inari Medical Files Patent Infringement Lawsuit Against Imperative Care and Truvic Medical
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
-
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inari Medical
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
-
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference
-
Inari Medical Reports First Quarter 2024 Financial Results
-
Inari Medical to Announce First Quarter 2024 Financial Results
-
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
-
Inari Medical (NARI) Appoints Tim Benner as Senior Vice President of U.S. Sales, Dr. Andrew Niekamp as Vice President of Medical Affairs
-
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives

